newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

SAN DIEGO and REDWOOD CITY, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that the Co